Skip to main content
The HRT Index

Equelle Reviews: Does It Work, Is It Safe, and What Does It Cost?

HI
The HRT Index Editorial TeamIndependent women's health research
Editorial research — not medically reviewed by a clinician. Why this label

Last updated: · Last verified: · By The HRT Index Editorial Team. Educational research, not medical advice, and not reviewed by a clinician. · See our medical review policy. Full disclosure.

Equelle reviews are mixed. In its main placebo-controlled trial, S-equol reduced hot flashes by about one a day more than placebo in postmenopausal women who started with about three a day. The Menopause Society does not recommend equol for hot flashes; the trial cannot predict your benefit or make it a substitute for clinician-led care.

Considering Equelle? These are the conditions to think through:

  • You want a nonprescription option and understand that the evidence is limited.
  • You've discussed any reason you cannot take hormones; that does not automatically make Equelle suitable.
  • You don't have a soy allergy or sensitivity.
  • You'll track what changes and review the next purchase, rather than let a subscription run on hope.

Skip it, or ask a clinician first, if:

  • Hot flashes or night sweats wake you most nights, or get in the way of work or driving.
  • You have a soy allergy.
  • You've had breast or uterine cancer. Ask your oncology team first.
  • You already tried Equelle for 12 weeks without enough relief.
  • Your main problem is vaginal dryness or painful sex.
  • You have any bleeding after menopause. Get that checked now.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

What we actually verified · Last verified October 2026

We read, on October 16, 2026: Equelle's product page, FAQ, clinical-research and S-equol research pages, and its purchaser terms (last modified December 23, 2025). We checked the live 2,715-review breakdown, the published abstracts of Aso 2012, Jenks 2012, Tousen 2011, Daily 2019 and Utian 2015, the relevant text and evidence table in The Menopause Society's 2023 nonhormone position statement, prescribing and safety information for two non-hormonal prescriptions, and Gala Health's and Midi Health's public offers and terms.

We confirmed: Equelle's three published prices and stated billing intervals; its current two-tablet directions and the brand's stated 10 mg daily amount; the soy and medicine-spacing warnings; the guarantee's customer, timing and bottle limits; and the five-business-day cancellation rule. We recalculated the review percentages, costs and calendar examples.

We did not: buy, take or lab-test Equelle, contact providers, complete a checkout or consult, or visually verify the current bottle's Supplement Facts panel. Abstract review is not full-paper review, and a published offer is not a tested checkout.

We could not confirm: the current tablet count per bottle, the full report behind the sleep claim, Equelle's exact holiday/cutoff convention, or Gala's complete HRT-specific checkout and medication terms. The calculations below state their assumptions.

Disclosure: We earn nothing from Equelle, and our Equelle links go straight to its official site. We may earn a commission if you start care through a Gala Health link on this page. That doesn't mean hormone therapy, or Gala, is right for you. How our affiliate links work.

Your situationOur answerYour next step
Prefer a supplement after discussing relevant safety concernsThe evidence is limited; the guarantee can reduce purchase risk, not medical riskRead the cost and refund sections, then see Equelle's current offer
Hot flashes or night sweats wreck your sleep most nightsYou do not have to wait through a supplement trial before asking for careConsider clinician care; Gala's advertised cash-pay HRT offer is one route to review below
Already tried Equelle 12+ weeks without enough reliefAnother bottle is not your only next stepJump to If Equelle isn't working
Breast or uterine cancer historyDon't decide from the words "hormone-free"Talk to your oncology team first; see safety
Not sure what kind of care fits youThat's a care-route question, not a supplement questionThe HRT Index's Find My HRT Path tool, after the evidence below

Already know the trade-offs and just want the details? Here's the official page with the published price and guarantee terms: See Equelle's current offer and terms.

If your nights are the problem and you're ready to discuss treatment, consider a clinician-led route. Gala advertises HRT at $69 a month; confirm the full medication and payment terms before paying.

A clinician-led care option

Review Gala's $69 HRT offer

Affiliate link. Cash-pay care; treatment and a prescription are not guaranteed.

On this page: Short answer · What Equelle is · Does it work · Claims checked · Real reviews · Cost · Refund and cancel rules · How long it takes · Safety · Equelle vs HRT · Equelle vs Gala · Other supplements · If it isn't working · FAQ


Equelle reviews: the short answer

Equelle reviews range from strong praise to reports of no benefit, while the research shows an uncertain, modest average hot-flash benefit. The Menopause Society does not recommend equol for hot flashes. A reader may still consider a purchase after discussing safety and accepting that uncertainty, but the refund does not turn it into a recommended medical treatment. (Aso 2012; The Menopause Society, 2023)

Here's our verdict in four lines:

  • Does it work? For some women, a little. On average, the main trial found about one extra hot flash a day gone, beyond what a placebo did.
  • Is it fairly priced? The published product price is $37 to $42 per bottle, sold as a 30-day supply. Subscription billing is every four or twelve weeks, not necessarily calendar-month billing.
  • Is the guarantee real? Yes, with conditions. It covers first-time Equelle.com customers only, up to three bottles bought during the guarantee period, and you must ask within 120 days of your first delivery.
  • Who should ask about care now? Anyone whose symptoms disrupt daily life, whose health history raises safety questions, or who wants options with stronger evidence.

The biggest evidence question is not whether somebody felt better. It's how much benefit the product adds, how reliable that benefit is, and whether it fits your needs. Safety still matters even when symptoms seem mild.

That doesn't mean "buy hormones instead." It means you should match the tool to the size of the problem, and keep another route open in case this one doesn't work.

A 30-second self-check

Answer these three questions honestly. Your answers point you to the right part of this page.

  1. Do hot flashes or night sweats wake you most nights, or affect work or driving? Yes: read Equelle vs Gala and Equelle vs HRT first. You don't have to try a supplement before asking for care.
  2. Do you have a soy allergy, or a history of breast or uterine cancer? Yes: Equelle says not to take it with a soy allergy or sensitivity. For a cancer history, ask your care team about this exact product. See safety.
  3. Will you track what changes and review whether another purchase is worthwhile? Yes: use the decision record and refund rules. These help organize a buying and care decision; they don't decide treatment for you.

What is Equelle, and who makes it?

Equelle is an over-the-counter dietary supplement made with S-equol, a soy-derived compound with estrogen-like activity. In the US, it's sold by Bonafide Health, LLC, doing business as Equelle, and Equelle's research page names Pharmavite as its parent company. It contains no human or animal hormones and is not prescription hormone therapy. (Equelle terms; Equelle clinical-research page)

What S-equol is, in plain words

When some people eat soy, their gut bacteria turn a soy compound called daidzein into equol. Not everyone has those bacteria.

Estimates of who does vary:

  • Equelle says about 1 in 5 American women.
  • The Menopause Society's 2023 statement says about 35% of North American women. (The Menopause Society, 2023)

Equelle gives you S-equol directly, so your gut doesn't have to make it.

S-equol attaches preferentially to estrogen receptor beta, one of the body's two main "docking spots" for estrogen. It is a phytoestrogen—a plant-related compound with estrogen-like activity—not estradiol replacement. Equelle's hormone-free footnote describes the absence of human or animal hormones, not the absence of an effect on estrogen pathways. (The Menopause Society, 2023; Equelle's wording)

What's in a serving

ItemWhat Equelle states (checked Oct 16, 2026)
Key ingredientS-equol; the current welcome page states 2 tablets provide 10 mg daily. This is a brand-published amount, not our independent label or lab test.
Directions2 tablets daily, with food if your stomach is sensitive; tablets can be crushed
Inactive ingredientsDicalcium phosphate (a calcium source), fermented soy germ, silicon dioxide, croscarmellose sodium, magnesium stearate, coating (hypromellose, glycerin, hydroxypropyl cellulose), microcrystalline cellulose
AllergenContains soy; Equelle says not to take it with a soy allergy or sensitivity
Soy sourceNon-GMO soy (Equelle says it is tested and certified)
Where it's madeS-equol from Japan; tablets made in the US
Where to buyequelle.com; Amazon listings exist; Equelle says it's not in stores and doesn't ship internationally

Older reviews sometimes describe four tablets a day. That is not necessarily a mix-up with Japan: Otsuka's 2019 US launch announcement described a 120-tablet bottle with four tablets providing 10 mg daily. The current US welcome page says two tablets provide 10 mg daily. Read the label on the bottle you receive, and don't double up to match an old review.

Some review sites name a different maker, or call Equelle "organic." Equelle's own pages describe non-GMO soy, not organic, and list Bonafide Health, LLC (doing business as Equelle) as the seller.

Is Equelle legit?

Yes. Equelle is a real product sold by an identified supplement business. Dietary-supplement manufacturing and labeling are regulated, but that is not an FDA endorsement or a manufacturing inspection we performed.

It is not FDA-approved. The FDA doesn't approve supplements for safety or effectiveness before they're sold. (FDA: Dietary Supplements)

You may notice a "Pharmavite Disclosure" link at the top of Equelle's site. It leads to a proposed class-action settlement about website accessibility for blind and low-vision users across several Pharmavite-related websites. It isn't about Equelle's safety or effectiveness. A final court hearing was scheduled for October 20, 2026. (Pharmavite ADA settlement notice)


Does Equelle actually work? What the trials show

In the main placebo-controlled trial, women taking 10 mg of S-equol daily for 12 weeks had about 1.9 fewer hot flashes a day, compared with about 1.0 fewer for women taking a placebo. That's roughly one extra hot flash a day gone, in women who started with about three a day. The Menopause Society finds the broader evidence mixed and does not recommend equol for hot flashes.

A placebo is a comparison pill without the studied active ingredient. Both groups can improve because symptoms fluctuate, expectations affect reported experience, and other changes happen during a study. The useful question is not just "did women improve?" It's "did they improve more than the placebo group?"

The trials in plain English

StudyWho was studiedWhat they took, and how longWhat happenedWhat it means for you
Aso et al., 2012 — the main placebo-controlled trial (abstract)160 postmenopausal Japanese women who didn't make equol on their own, each with at least 1 hot flash a day; 126 finished10 mg S-equol a day, or placebo, for 12 weeksHot flashes fell by 1.9 a day (−58.7%) on S-equol vs 1.0 a day (−34.5%) on placebo. Hot-flash severity and neck or shoulder stiffness also improved. No serious side effects reported.About 0.9 extra hot flashes a day gone beyond placebo, from a starting point of about 3 a day
Jenks et al., 2012 — the US pilot (abstract)102 US postmenopausal women aged 45–65 with 5 or more hot flashes a day10, 20 or 40 mg S-equol a day vs soy isoflavones, for 8 weeks — no placebo groupAt week 8, hot-flash reductions were similar across groups. In the cumulative eight-week analysis, 40 mg did better than soy isoflavones. A subgroup analysis found benefits with 20 and 40 mg among women starting above 8 hot flashes a day. The 10 and 20 mg groups had better muscle/joint pain scores than the soy group.The 10 mg group did not show a greater week-eight hot-flash reduction than soy isoflavones in this pilot. That is not proof of equivalence or a reason to increase the retail dose.
Daily et al., 2019 — meta-analysis (abstract)6 studies reviewed (779 women); 5 combined (728 women)Equol supplements, or soy in women who make equolThe pooled result favored equol-related interventions for hot-flash scores. 2 of the 5 combined studies found no significant benefit.A positive pooled signal, but not a consistent one—and not five trials of today's retail Equelle product
Utian et al., 2015 — review (abstract)A review of S-equol research available in 2015—Trials were small and primarily in Japanese women. The US hot-flash study discussed in that review had no placebo. The authors found limited safety data reassuring but called for more study.Promising early evidence, not a current inventory of every later study
The Menopause Society, 2023 (statement)An expert panel's review of non-hormone treatments—Soy metabolite equol: Level II, not recommended for hot flashes; evidence mixed. Hormone therapy remains the most effective treatment for hot flashes.The main US menopause society doesn't recommend it, but "not recommended" isn't "proven useless"
Editorial illustration of a soybean, an unbranded supplement tablet and a research paper; not a photograph of Equelle or a clinical result.
Editorial illustration only; it is not the Equelle product, an ingredients label, or a visualization of a study result.

Put the hot-flash results in everyday numbers

The trial reports averages. Here's what they mean in daily life.

The core calculation: 1.9 fewer a day on S-equol, minus 1.0 fewer a day on placebo, equals 0.9 fewer hot flashes a day beyond placebo. Over a week, that's about 6 fewer (0.9 × 7 = 6.3).

An illustration, not a prediction for you:

  • The S-equol group started at an average of about 2.9 hot flashes a day. Subtracting its 1.9 reduction leaves about 1.0 a day.
  • The placebo group started at about 3.2 a day. Subtracting its 1.0 reduction leaves about 2.2 a day.
  • The groups started at slightly different averages. The 0.9 figure compares their reductions; it is not the total reduction every woman can expect.

Now say you start at 10 a day. You cannot simply subtract 0.9 and predict that you will end at nine. The study does not establish your individual result at that starting point.

That's why the size and impact of your problem matter more than a star rating—and why averages need their limits attached.

A few limits keep this honest:

  • The main trial was in postmenopausal women. It didn't directly establish the same benefit in perimenopause, the years of changing cycles before your final period.
  • The women didn't make equol on their own. Results may differ for women who do.
  • The main trial started with a relatively low frequency of hot flashes; frequency alone does not establish how severe or distressing they were. The US pilot with more frequent hot flashes had no placebo group.

Why a positive study isn't the same as a recommendation

The Menopause Society's 2023 panel looked at all the equol studies together. It found the results mixed, with small studies and design limits. So it rated equol Level II, not recommended for hot flashes. (The Menopause Society, 2023)

That doesn't mean women who feel better are imagining it. Their relief can be real. It means the evidence isn't strong or consistent enough to call equol a reliable treatment.

The practical meaning: do not turn a retail trial into a treatment plan. Track what matters to you, review the next purchase, and ask about care whenever you need it—not only after a bottle is finished.

If the evidence leaves you wanting a clinician's input, you don't have to guess at your next step. The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.

It's free, takes about 60 seconds and doesn't ask for your email. You'll answer five questions: what's bothering you most, what you've tried, your age, your state, and relevant health history. It points you to a featured online option, or to guidance when online care isn't the right first step. It doesn't diagnose anything or decide whether you should take hormones. Our published tool explanation says answers are processed in your browser and aren't stored. We may earn a commission from featured providers, and that affects which ones appear. How the tool works.


Equelle's claims, checked

Equelle has published research behind some claims, but the type of evidence matters. A hot-flash trial, a bone-density study, a company sleep report and customer satisfaction are not interchangeable proof. Here's what the cited sources actually support.

What Equelle saysWhere we saw itWhat the evidence showsOur read
"Clinically studied" menopause supportHome pageS-equol has been tested in randomized trials (Aso 2012; Jenks 2012)True. Studied doesn't mean recommended.
Fewer hot flashesProduct pageAbout 0.9 fewer a day beyond placebo in the main trial; the 10 mg group did not outperform soy isoflavones at week eight in the US pilotA modest average benefit in one placebo-controlled trial; broader evidence is mixed
Better sleepProduct pageEquelle's footnote identifies a change from baseline, not a significant advantage over placebo. It cites company data on file and a 2021 conference poster. We did not obtain those full reports.The cited marketing footnote does not establish a placebo-adjusted sleep benefit
Relieves muscle achesProduct pageNeck/shoulder stiffness improved vs placebo in Aso 2012; muscle/joint pain scores improved vs soy in Jenks 2012Specific outcomes in small trials—not treatment for every cause of pain
Supports healthy bonesProduct pageTousen 2011 studied 93 Japanese women for one year, measuring bone breakdown and bone mineral density. The 10 mg group had a favorable bone-marker result and avoided a decline in whole-body bone density.More than marker data alone, but not proof of fracture prevention or a replacement for osteoporosis care
Hormone-freeBrand pagesThe brand defines this as no human or animal hormones. S-equol still binds estrogen receptors.No hormone replacement in the bottle does not mean no estrogen-like activity
Doesn't change estrogen levelsFAQTousen's one-year study reported no between-group differences in measured sex or thyroid hormone concentrations after intervention.A limited study finding, not proof of no estrogen-related effects or universal safety
86% satisfactionProduct pageA brand-published satisfaction figure. Its complete survey methods and denominator were not verified from an applicable primary source.Not a clinical response rate; do not use it as your odds of benefit
Four randomized placebo-controlled trials; elsewhere, three double-blind randomized trialsFAQThese descriptions could refer to different sets of studies. The counts were not reconciled to full reports; Jenks 2012 used an active comparator, not placebo.Different counts alone do not prove a contradiction. Judge the named trials, not the headline count.
About one in five American women make S-equolFAQUtian 2015 gives about 25% of non-Asians; the 2023 Society statement gives about 35% of North American women. These are different populations and estimates.Do not merge them into a precise personal probability
Recommended by health professionalsClinical pageThe quoted practitioners are labeled Equelle Medical Partners; other quoted staff have company roles.Brand-affiliated endorsements, not independent clinical verification
Safe, with no link to breast cancerFAQLimited research has not established a long-term cancer-safety guarantee. The bone study lasted one year; the two hot-flash trials above lasted eight and twelve weeks. Equelle itself advises physician input after breast cancer.Ask your oncology team first; hormone-free is not automatic clearance

What Equelle doesn't claim, and shouldn't be expected to do

What you might hope forWhat we foundWhat not to expect
Weight lossNo clinical evidence establishing a weight-loss benefit was verified for this reviewFat loss or GLP-1-like results
Vaginal dryness or painful sexNot an outcome established by the hot-flash trials aboveAssuming this supplement replaces targeted vaginal-symptom care
Bone protectionA one-year pilot measured bone breakdown and bone density, not fracture preventionFewer fractures, or a substitute for osteoporosis care
Replacing HRTNo head-to-head S-equol-versus-HRT trial was verified for this reviewAssuming equivalent relief or replacing a prescription

What do real Equelle reviews say?

On Equelle's own site, 2,715 reviewers give it an average of 4.2 out of 5, but about 1 in 4 gave three stars or fewer. The individual reviews we read included reports of benefit, symptoms returning after a pause, and—on Reddit—no meaningful change. Those examples do not tell us which experience is typical.

How the stars break down

StarsShare of reviewsNumber of reviews
★★★★★63%1,706
★★★★14%384
★★★10%276
★★5%134
★8%215
Average4.2 out of 52,715 reviews

Source: Equelle product page, checked October 16, 2026. 625 of 2,715 reviews (23%) are three stars or fewer; 349 (13%) are one or two stars. Equelle says its on-site reviews are unfiltered.

What reviewers keep saying

  • It took time. Tammi H., in a brand-hosted review dated October 11, 2026, wrote that it "took about three months to completely work." Other readers should not treat her timeline or outcome as a promise.
  • Symptoms returned after a pause. Sara G. and Kimberly B., in the visible product-page reviews, described noticing symptoms when they ran out or stopped. These are personal reports, not proof of causation.
  • Nothing changed. The Reddit discussion includes people reporting little benefit. We did not read every one- or two-star review, so we cannot say what most low-rating reviewers experienced.
  • Cancellation was straightforward for one reader. In r/Menopause's "Does Equelle work?" thread, u/Kacodaemoniacal said: "It was very easy to cancel." That's an older, unverified-purchase account, not a test of today's process. Read the thread.

Why Equelle reviews can disagree

  1. People start in different places. Three hot flashes a day and twelve a day are different experiences; frequency and impact both matter.
  2. Comparison groups improve too. In the main trial, the placebo group's reported hot flashes dropped by about a third. That does not tell us why any particular reviewer improved.
  3. Other things change. Symptoms and other treatments may change during the same weeks. A review rarely separates every influence.
  4. Timing. Someone reviewing at week three and someone reviewing at month four are describing different moments.

That's why we don't combine brand reviews, retail ratings and forum comments into one "average result." Mixing them would create a number that looks more reliable than it is. Reviews can tell you what questions to ask. They can't tell you your odds.


How much does Equelle cost per month and per year?

Equelle's published product price is $37 to $42 per bottle, sold as a 30-day supply. Three bottles cost $111 to $126 before any tax or one-time shipping. Subscriptions renew every four or twelve weeks, so your card can be charged for the next shipment before you finish the advertised supply. A supply cost and a first-year cash total are different numbers.

The Equelle 90-Day Decision Sheet, part B: purchase math

How you buyAmount due for the first order, before extrasPublished billing intervalThree-bottle product subtotal (advertised 90-day supply)Charges inside days 1–90 if the first charge is day 1Charges inside days 1–365 on the same schedule
90-day subscription$111 for 3 bottles, advertised as $37 per bottle/monthEvery 12 weeks (84 days)$111Days 1 and 85: $222, buying 6 bottlesDays 1, 85, 169, 253 and 337: $555, buying 15 bottles
30-day subscription$39.90 for 1 bottleEvery 4 weeks (28 days)$119.70Days 1, 29, 57 and 85: $159.60, buying 4 bottles14 charges = $558.60, buying 14 bottles; charge 14 is on day 365
Buy once$42 for 1 bottle; a 3-bottle order is $126Only when you order; no automatic renewal$126Only the orders you choose$546 if you buy 13 bottles; at the advertised 30 days each, that is 390 days of supply. Twelve bottles cost $504 but represent only 360 advertised days.

Source: Equelle product page, FAQ and purchaser terms, checked October 16, 2026. The charge columns are calculations, not charges we observed: first purchase is day 1, the final day is included, prices stay unchanged, and renewals follow the stated interval from that first charge. Check your account's actual processing dates. Subscription shipping is advertised as free. The FAQ also says US shipping is free, but the terms allow fees on individual one-time boxes; check checkout. Tax and any one-time shipping are not included, so these are product subtotals, not complete delivered totals.

For a rate comparison, not a first-year bill: 52 weeks equals 364 days. The quarterly plan's 52-week billing-rate equivalent is $111 × 364 ÷ 84 = $481; the four-week plan's is $39.90 × 13 = $518.70. Those rates are not the cash totals above and do not describe exactly how much supplement you consume. Based only on the advertised 30-day bottle, the product cost per supply day is about $1.23, $1.33 or $1.40 respectively.

A worked example. You choose the $111 plan. Your first three bottles cost $111. If your account renews 84 days after that first charge and you don't cancel in time, another $111 processes on day 85, and $222 hits your card within the first 90 days. The first three bottles didn't cost $222. You bought the next three during the same review window.

Promotions vs the real price

Equelle's site showed a first-order code (15% off your first payment) when we checked. That's a one-time promotion, so we don't build totals on it. Equelle's pages also don't fully agree:

  • The product page: $39.90 on subscription, $42 one-time.
  • The healthcare page: "$40/month" on subscription, "$50/month" one-time.
  • The $37 figure is the product page's per-bottle price when you pay $111 for three bottles—not a separate $37 first payment.

The price at your checkout is the one that counts. Neither the healthcare page's $50 one-time figure nor an old discount should silently replace the current product-page offer in your budget.

Can you use an HSA or FSA?

Maybe. Equelle says it may be eligible if a healthcare provider completes its Letter of Medical Necessity. You'd submit that letter with your receipt to your account administrator. That's possible reimbursement, not guaranteed coverage, and it isn't the same as health insurance paying.

The $30 question

Here's the comparison worth making—without pretending a bottle and a care subscription are the same product.

PathAdvertised costWhat you get
Equelle$37–$42 per bottle, sold as a 30-day supply; subscriptions renew every 28 or 84 daysA supplement. No clinician is included.
Gala Health HRT$69/month on its dedicated HRT offer, checked October 16, 2026According to Gala: clinician review, prescribed medication if appropriate, shipping, and ongoing support; confirm your exact regimen and required extras
The sticker-price difference$27–$32 ($69 − $42; $69 − $37)A useful starting comparison, not a verified difference in complete monthly costs. Billing dates, medicines and monitoring can change the total.

For a worked cash-flow comparison, 12 charges of $69 equal $828. If a $69 plan instead billed every 28 days, 14 charges would fall within days 1–365, totaling $966. Gala's exact HRT billing cadence was not established through checkout, so these are alternatives to clarify, not two confirmed Gala plans. Under the four-week Equelle schedule above, the comparable cash total is $558.60; the conditional differences are $269.40 or $407.40, before any missing costs.

Gala's $69 is an advertised HRT price, not a verified total for every medication or non-hormonal prescription. Before you pay, confirm the amount due now, billing interval, all required medicines and any labs. More on Gala's strengths and limits below.


How does Equelle's 90-day money-back guarantee work?

Equelle's guarantee covers up to three bottles for first-time Equelle.com customers, with a request required within 120 days of the first delivery. The bottles must fall within the guarantee's stated purchase period. Amazon purchases go through the seller instead. To prevent a subscription renewal, the terms require cancellation at least five business days before the next processing date. (Purchaser terms)

The rules, from Equelle's own terms

RuleWhat Equelle's terms and FAQ say (checked Oct 16, 2026)
Who's coveredFirst-time customers at Equelle.com
How muchUp to three bottles bought during the stated 90-day guarantee period
DeadlineWithin 120 days of your first delivery
How to askEmail hello@equelle.com, or use the contact form, with your order number
ReturnsEquelle doesn't accept returns; refunds go to your original payment method
AmazonEquelle can't refund Amazon orders; contact the Amazon seller
Cancelling a subscriptionAt least 5 business days before your next processing date (purchaser terms, last modified Dec 23, 2025)
Reminder emailEquelle's FAQ says you'll get an email 3 days before a renewal

Notice the mismatch. The reminder email arrives 3 days before renewal. The terms say you must cancel 5 business days before. If you wait for the reminder, you may already be too late. Put your own reminder on the calendar.

Worked example: a 30-day subscription

These dates illustrate an unchanged four-week billing schedule—not a delivery promise or your account's confirmed deadline. Delivery is also the assumed first-use date in this example. Day 1 means that starting date; day 84 is 83 days later. The refund clock always uses first delivery, even if you begin using the product later.

EventDateWhy it matters
First order processesFriday, Oct 16, 2026Assumed anchor for this example's billing schedule
First delivery and assumed first useThursday, Oct 22, 2026Starts the refund clock; also day 1 of this example's notes
Bottle 2 would processFriday, Nov 13, 2026Bottle 2 of the three-bottle cap, if other guarantee conditions are met
Bottle 3 would processFriday, Dec 11, 2026Bottle 3 of the cap, if other conditions are met
Early reminder to review the next orderTuesday, Dec 29, 2026An editorial reminder ten calendar days before the projected renewal—not the contractual cutoff
Illustrative five-business-day pointThursday, Dec 31, 2026Counting Monday–Friday and excluding Jan 1. Equelle's terms do not define holidays or a cutoff time; confirm the actual deadline and act earlier.
Bottle 4 would processFriday, Jan 8, 2027An additional bottle beyond the three-bottle guarantee cap
Day 84 of the decision recordWednesday, Jan 13, 2027The 84th calendar day counting Oct 22 as day 1; twelve full elapsed weeks end Jan 14
Earlier refund-request reminderFriday, Feb 12, 2027Seven days before the calculated 120-days-after-delivery marker
120 days after first deliveryFriday, Feb 19, 2027Date arithmetic, not permission to wait until a last-minute cutoff; the terms say to contact Equelle within 120 days

The bottle-4 trap: the next renewal can arrive before you've had twelve weeks with the product. In this example, the holiday-adjusted five-business-day point falls on day 71 after delivery—but day 71 is not a rule for every customer. Use your actual account date and cancel earlier when you don't want another shipment. Canceling future orders is separate from reviewing the product already purchased and requesting a qualifying refund.

The 90-day plan has the same timing issue. One $111 charge buys three bottles. Under an unchanged 84-day cycle, the next $111 charge in this example falls on January 8. The same advance-cancellation requirement applies.

Before-you-buy checklist

Ask or recordWhy
Am I buying at Equelle.com?Only those orders get Equelle's guarantee
Is this my first Equelle order?The guarantee is for first-time customers
My first delivery dateThe 120-day refund clock starts here
My next processing date (in my account)Cancel at least 5 business days before it
How do I cancel?Log in at equelle.com or email hello@equelle.com
ProofSave your order number and the cancellation and refund confirmation emails

Stopping your subscription, asking for a refund and deciding whether to see a clinician are three separate tasks. Doing one doesn't do the others.

If you've discussed relevant safety concerns, understand the evidence and still want to consider Equelle, review the terms before buying: See Equelle's 90-day plan and guarantee.

Equelle refund and cancel planner

Use the dates in your account and the worksheet below to separate three decisions: the next shipment, a refund request, and your care. Record your real delivery date rather than guessing when a parcel will arrive. The worked example above stays useful without entering any information online.

A clinician-led care option

Review Gala's $69 HRT offer

How long does Equelle take to work, and what should you track?

Equelle says changes may appear around a month, with fuller effects by about three months. That is a brand timeline, not an individual promise. The main hot-flash trial measured results at twelve weeks; a record can help you discuss changes and decide about further spending, but you do not have to wait twelve weeks to ask for care.

What Equelle says to expect

TimeEquelle's description (brand claim)
Around day 30First signs, such as fewer hot flashes
Month 2Symptoms may keep improving
Month 3Relief from hot flashes, muscle aches and sleep issues may be at its fullest
Month 4 and beyondEquelle recommends staying consistent

How to take it

Follow the directions on the bottle you receive. Equelle's current US pages state two tablets daily and suggest food if supplements upset your stomach. The 2015 research review describes a roughly 7–10-hour half-life—the time for the amount in circulation to fall by about half—not a limit on how long all effects last. Some research used split doses, but that does not establish a better schedule for the current product. Ask a pharmacist rather than changing directions to match a study.

The 12-week Equelle decision record

This is an observation and shopping aid, not an instruction to start a supplement, adjust treatment or stop at a symptom threshold.

  1. Record a starting point. When practical, note one symptom for seven days before a clinician-agreed change: hot flashes per day, or nights you wake up soaked. Use the same measure each time. Do not delay needed care to collect a baseline.
  2. Write what meaningful improvement would look like. For example: "I want fewer nights when I wake soaked and cannot get back to sleep." This is a discussion goal, not a medical pass/fail rule.
  3. Check in around day 28. Not a final answer. Just a look.
  4. Review the next shipment before your account's cancellation deadline. That date can fall before twelve weeks of use; there is no universal day-71 cutoff.
  5. Review your notes around twelve weeks, or sooner when needed. Day 84 in the worksheet is the 84th calendar day, counting the start as day 1.
  6. Record other changes too. New treatment, illness, alcohol, stress or sleep changes can affect what you notice. Do not postpone clinician-directed care to make a cleaner home experiment.
  7. Keep the refund task separate. When you qualify and want a refund, request it well within 120 days of first delivery, whether or not you started taking the product on delivery day.

Your private decision record

Copy this into private notes or print the companion sheet. It is for you and your clinician; you do not need to send it to The HRT Index. A notes app or calendar may sync through its own service, so choose where to keep health information.

What to writeYour entry
Main problem I want help withe.g., "Night sweats wake me 4 nights a week"
My 7-day starting count
What meaningful improvement would look likeA discussion goal, not a treatment stop rule
First delivery date / actual first-use dateKeep these separate if they differ
Day 28 check-in date and notesFirst-use date + 27 days
Next account processing date / early cancellation reminderConfirm the provider's deadline; don't rely on a guessed holiday rule
Day 84 review date and notesFirst-use date + 83 days
Earlier refund-request reminder / 120-days-after-delivery markerThe terms require contact within 120 days; act earlier
Other changes during these weeksIllness, stress, new medicines, travel, alcohol
Anything new or unwanted I noticedWhat happened and when — bring this to a clinician
My question for a clinician"Is there a better option for this problem?"
My next decisionDiscuss care / review another purchase / cancel future shipments / request a qualifying refund / no new purchase

A tracker can't prove that Equelle caused a change. It can stop a monthly purchase from drifting into a year of "maybe."


Is Equelle safe? Side effects, interactions and who should ask first

The main twelve-week hot-flash trial reported no serious adverse events, and Equelle warns that stomach upset can occur. That does not establish long-term safety for everyone. Don't take it with a soy allergy or sensitivity; ask a pharmacist about iron or thyroid medicine. A breast or uterine cancer history belongs with your oncology team, not a hormone-free label.

Side effects

Equelle says plant-based supplements can cause stomach upset, and suggests taking it with food. The main trial reported no serious adverse effects or changes in the clinical parameters reported over 12 weeks (Aso 2012).

The safety evidence is limited, but not every study lasted only eight to twelve weeks: Tousen 2011 followed 93 women for one year. That small study still cannot settle uncommon harms or long-term cancer safety. Equelle's statement that no long-term side effects are known is not a guarantee that none can occur.

Who should check first, and what to ask

Your situationWhat to do
Soy allergy or sensitivityDon't take Equelle. Equelle itself says not to.
Breast or uterine cancer, now or in the past, or another hormone-sensitive conditionAsk your oncology team about this exact product before starting. S-equol binds estrogen receptors, and long-term data are thin. Equelle also says to ask your physician.
Thyroid medicineEquelle says to take it 4 hours apart from thyroid medication, because its tablets contain calcium. Confirm with your pharmacist.
Iron, or a multivitamin with ironEquelle says to space them 1–2 hours apart.
Already on hormone therapyAsk the clinician managing your HRT before adding anything. Don't stop or change a prescription on your own.
HysterectomyEquelle says to ask your physician.
Pregnant, breastfeeding, or new symptoms you can't explainStart with a clinician, not a supplement.
Several medicines or supplementsBring the bottle and your full list to a pharmacist.

"Hormone-free" isn't the same as "no effect on estrogen pathways"

Equelle contains no human or animal hormones. But S-equol interacts with estrogen receptors, with a preference for the beta type. That estrogen-like activity is part of the reason it has been studied for menopausal symptoms—and a reason to discuss a history that makes estrogen-related decisions complicated. (The Menopause Society, 2023)

A review of the research found the limited safety data didn't suggest harm to breast or uterine tissue (Utian 2015). Limited isn't the same as long-term proof. If you've had a hormone-sensitive cancer, your oncology team is the right place to decide.

And if hormones aren't an option for you, keep this in mind: "I can't take systemic hormones" is not the same as "there's nothing effective I can take." There are FDA-approved non-hormonal medicines, covered below, and your care team can tell you which fit your history. Menopause treatment options for breast cancer survivors.

Don't wait for a refund deadline to get help

A money-back window is a shopping term, not a medical schedule. Get clinical advice promptly for:

  • Any bleeding after menopause, or a new unexplained change in bleeding.
  • Hot flashes or sleep loss that affect your safety, driving or ability to function.
  • A suspected supplement reaction or a new symptom that's severe, worsening or frightening. FDA advises stopping a supplement and seeking medical care or advice after an adverse reaction.

Call 911 for trouble breathing, throat or tongue swelling, chest pain, fainting, sudden weakness on one side or trouble speaking. Do not route an emergency through a supplement review or an online quiz. (FDA supplement safety; MedlinePlus: anaphylaxis)


Is Equelle the same as HRT? Equelle vs prescription options

No. Equelle is a supplement with estrogen-like activity. Systemic menopausal hormone therapy is prescription treatment that acts throughout the body; an estrogen regimen generally needs a progestogen, such as progesterone, to protect the uterine lining when you have a uterus. The Menopause Society calls hormone therapy the most effective hot-flash treatment. When hormones are unsuitable or unwanted, prescription non-hormonal options also have stronger evidence than equol. (The Menopause Society)

Wanting to avoid hormones doesn't mean supplements are your only choice. Here's how the main routes compare. This table helps you prepare for a conversation. It isn't a ranking, or a recommendation for your situation.

OptionWhat it isPrescription?FDA statusEvidence for hot flashesKey thing to knowLearn more
Equelle (S-equol)Dietary supplementNoSupplement; not FDA-approved for any useSmall trials; The Menopause Society: not recommended (Level II)Soy allergy; long-term data thinThis page
Systemic hormone therapy (estrogen, generally with a progestogen when you have a uterus)Hormone medicine; options include pill, patch, gel or sprayYesMany FDA-approved finished products; confirm the exact oneThe most effective treatment for hot flashes (The Menopause Society)Not for everyone; medical history, route and regimen matterHRT for hot flashes
Fezolinetant (Veozah)Non-hormonal pillYesFDA-approved for moderate to severe hot flashesRecommended (Level I, 2023 statement)Boxed warning for rare serious liver injury; liver blood tests before starting, monthly for 3 months, then at months 6 and 9FDA Veozah liver warning
Elinzanetant (Lynkuet)Non-hormonal capsuleYesFDA-approved Oct 24, 2025, for moderate to severe hot flashes due to menopauseApproved after the 2023 statementLiver tests before starting and at 3 months; warnings about sleepiness/daytime impairment, seizure risk and pregnancy loss. It is contraindicated in pregnancy. Review the current label with a clinician.Lynkuet prescribing information
Low-dose paroxetine, other SSRIs/SNRIs, gabapentinNon-hormonal medicinesYesLow-dose paroxetine (Brisdelle) is FDA-approved for hot flashes; others are used off-labelRecommended (Level I, 2023 statement)Drug interactions and side effects varyParoxetine · Gabapentin
Non-drug: cognitive behavioral therapy, clinical hypnosisStructured therapyNot a medicineNo drug-approval statusRecommended (Level I, 2023 statement)CBT can reduce symptom bother and interference; clinical hypnosis also has evidence for reducing hot flashesNon-hormonal options

Source: The Menopause Society 2023 statement; FDA Veozah safety communication; Lynkuet prescribing information and FDA approval snapshot. "Off-label" means a clinician prescribes an approved drug for a use not listed on its label. FDA's April–June 2026 signal table listed Lynkuet seizures under evaluation as of September 4; that dated signal report does not cancel the seizure precaution in current prescribing information.

Local vaginal treatment is a separate question. Low-dose vaginal estrogen targets vaginal dryness and related symptoms, not hot flashes. Vaginal moisturizers are another local option. A need for vaginal care does not, by itself, mean you need systemic hormones. Read about vaginal estrogen.

Three categories that aren't interchangeable

  1. Supplements, like Equelle. Not FDA-approved. The maker is responsible for safety and labeling.
  2. FDA-approved hormone therapy. The finished product was reviewed by the FDA for safety, effectiveness and quality.
  3. Compounded hormones. A pharmacy mixes them for an individual patient. The finished products are not FDA-approved. (FDA on compounding)

"Bioidentical" describes the shape of a hormone molecule, not whether a product is approved. Compounded vs FDA-approved HRT.

Can you take Equelle with HRT?

Ask the clinician managing your hormone therapy, and your pharmacist, about this exact product. "Hormone-free" doesn't remove the need to ask. Don't use Equelle to replace a prescription, or add it to one, without that conversation.


Equelle vs Gala Health: what the added cost buys

Equelle is a $37–$42-per-bottle supplement. Gala Health's dedicated HRT offer advertises $69 a month for clinician review, prescribed medication if appropriate, shipping and ongoing support. The added value is access to a clinician who can assess you and discuss treatment—not a promise of a prescription or proof that Gala's care outperforms another service. Confirm your full HRT terms and required costs first. (Gala HRT offer)

Where Gala makes sense for an Equelle reader

If this is youWhy Gala fitsWhat Gala says it offers (checked Oct 16, 2026)
Hot flashes or night sweats disrupt sleep most nightsHormone therapy is the most effective treatment for hot flashes, and a clinician can decide whether it's right for youEstradiol pill or patch; progesterone; "provider-led, not chatbot-led" care
You tried Equelle 12+ weeks without enough reliefA clinician can weigh what you've already triedA 5-minute online assessment reviewed by a US-licensed clinician
You want to avoid hormones but need more than a supplementNon-hormonal prescriptions have stronger evidence than equolNon-hormonal options; Gala's page names fezolinetant
Vaginal dryness or painful sex is a big part of the problemLocal vaginal estradiol targets those symptoms; Equelle wasn't studied for themVaginal estradiol cream or tablet
You pay cash, or want to use an HSA or FSAA bundled advertised price can be simpler, once the exact regimen and terms are clear$69/month on the dedicated HRT offer; the hormone-health page advertises FSA/HSA acceptance, free shipping and ongoing messaging

Gala says routine hormone testing often isn't needed to begin menopause care. That does not remove medication-specific monitoring: fezolinetant, for example, requires liver blood tests. Ask what is needed for your actual prescription and who arranges and pays for it.

One Gala patient, Allison, 51, is quoted on Gala's own site saying that "Gala's provider walked me through the options." That's a testimonial Gala chose and published, about the service. It isn't proof of results, and we didn't verify it independently.

The limits to know first

We want you to see these before you click:

  • Exact finished medicines aren't identified before intake. Gala describes hormone formulations and routes, but an alternate HRT landing page also carries a compounded-medication notice. That does not prove that every HRT prescription is compounded—or FDA-approved. Ask: "What exact finished product would I receive, and is that product FDA-approved?"
  • Non-hormonal pricing isn't shown separately. Gala names fezolinetant, but we did not verify that it is included in $69. Ask about the medicine and all required liver blood tests before treating the price as a total.
  • Payment and cancellation need HRT-specific confirmation. The HRT page says cancel anytime without a long-term contract. Its linked general policy says the first charge occurs at intake completion, requires cancellation at least 72 hours before billing, and generally excludes refunds except for medical disqualification. That policy uses weight-loss wording and varies between full-refund and remaining-charges wording. Ask exactly what is due now, whether it is taken before medical review, and which written HRT refund terms apply.
  • Age, state and continuity still matter. The HRT offer says most US states, not all. Its exact HRT age range and full state list were not established. Ask who handles follow-up, records and refills if the service or your subscription ends.
  • Its star rating isn't an HRT score. Gala's public reviews include its weight-loss program; they cannot establish the HRT patient experience.
  • It's cash-pay. Gala says it does not bill insurance. A covered clinician may fit you better.

These details can change the fit, especially when you need an FDA-approved product, a particular route, insurance or ongoing monitoring. Our full Gala Health HRT review has the complete checklist.

Care routes side by side

Care routeWhat you getPrice you'll seeInsuranceWhat to confirm
Gala Health (affiliate)Online clinician review, prescription if appropriate, ongoing messaging; hormone, local vaginal and non-hormonal options are listed$69/month advertised HRT offer; confirm medicines, labs, first charge and interval rather than assuming every option is includedCash-pay; FSA/HSA accepted according to GalaExact finished medicine and FDA status; required extras; age/state; HRT-specific cancellation/refund terms; continuity
Midi Health (not an affiliate)Scheduled video visits with menopause clinicians; prescriptions sent to your pharmacySelf-pay: $250 first visit, $150 returning visit; those are visit prices, not a complete medication/lab totalCheck your exact plan and state. Medicare is out of network; Midi allows self-pay but says associated services cannot be submitted for Medicare claims. Medicaid/Medi-Cal not accepted.Actual copay/deductible, prescriptions, labs, follow-up costs and any plan restrictions
Your own clinician or a menopause specialistContinuity with someone who knows your history; exams when neededDepends on your plan and practiceYour usual coverage, subject to plan rulesWhat evaluation and follow-up you need
EquelleA supplement, no clinician$37–$42 per bottle sold as a 30-day supply; renewal intervals differNot ordinary insurance coverage; possible HSA/FSA reimbursement with a clinician's letterExact processing dates, purchase conditions and refund window

Provider-published offers checked October 16, 2026: Gala HRT, Gala hormone-health options, Gala non-hormonal page, and Midi pricing and insurance. We did not complete a checkout or test the care.

Your next step

If hot flashes are waking you up, or Equelle hasn't helped enough, you don't have to buy another bottle before seeking care. A clinician can look at your whole history. When cash-pay online care fits, Gala's featured HRT offer is a direct route to review—confirm the exact medicine, total required cost and payment terms before paying.

Affiliate link. A licensed clinician decides whether any treatment is right for you; a prescription isn't guaranteed.

Want to avoid hormones but need more help than a supplement has provided? Gala publishes a separate explanation of its non-hormonal options. Read it first, then ask whether the medication and monitoring you need are available and what they cost.

Read Gala's non-hormonal options. This informational link is not an HRT checkout or a promise of $69 non-hormonal treatment.

Want your insurance to do the work? Start with the plan you already pay for: Check Midi's insurance and pricing, or see compare insurance options in our online HRT provider guide.


Equelle vs other menopause supplements

Equelle has human trial data, but The Menopause Society did not recommend equol or the supplement ingredients below for hot flashes in its 2023 statement. Different products have different evidence; changing brands does not automatically solve the evidence problem.

SupplementMain ingredient2023 Menopause Society finding for hot flashesOur review
EquelleS-equolLevel II, not recommendedThis page
Estroven CompleteRhapontic rhubarb extract (ERr 731)Level II, not recommendedEstroven review
Some Estroven formulasBlack cohosh and/or soy isoflavones; the exact formula mattersBlack cohosh: Level I, not recommended; soy extracts: Level II, not recommendedEstroven review
AmberenAmmonium succinate–based formulaLevel II, not recommendedAmberen review
Bonafide RelizenPurified pollen extractLevel III, not recommended—
Happy MammothIngredients vary by named productNo product-specific guideline finding was verified here; do not assign a guideline grade to the whole brandHappy Mammoth

Source: The Menopause Society 2023 statement. "Not recommended" can reflect evidence of little benefit, inconsistent findings, or insufficient evidence; it does not mean every user reported no benefit. The level describes the evidence category, not an effectiveness score.

Revaree belongs in a different comparison. It is a non-hormonal, hyaluronic-acid vaginal moisturizer—not an oral supplement for hot flashes. Keep it relevant to vaginal dryness rather than treating it as a failed hot-flash treatment. (Official product page; our Revaree review)

If you've been working your way down the supplement shelf, box by box, the panel already looked at most of it. The next sensible comparison may not be another bottle. It may be a non-hormonal prescription, cognitive behavioral therapy, hormone therapy if you're a candidate, or targeted treatment for vaginal symptoms.

See how these compare in best menopause supplements with evidence and phytoestrogens for menopause.


What if Equelle isn't working?

If Equelle hasn't helped enough, you don't have to keep buying out of hope. Review future shipments, request a refund when you qualify, and ask a clinician about other explanations and options with stronger evidence. A twelve-week review is an organizing aid, not a medically validated stop date or a reason to delay care.

A simple decision path

What you notice at your reviewWhat it tells you—and what it doesn'tNext step
Little or no improvementYou have not noticed the benefit you wanted; that does not diagnose the causeReview further spending and a qualifying refund; discuss care or use Find My HRT Path for navigation
Some help, but you're still waking up or strugglingA partial change may not meet your needsAsk a clinician about hormone therapy, non-hormonal prescriptions or another cause
Clear improvement that meets your goalYou noticed improvement; a home record cannot prove the supplement caused itDiscuss ongoing suitability as needed and decide whether another purchase is worthwhile
Doing well and considering a changeSome readers report symptoms returning after a pause, but your result is not predictableDiscuss treatment changes with your clinician and keep useful notes

What to bring to an appointment

  • Your Equelle bottle, or a photo of the label.
  • Your decision record, including dates and what changed—not just a pass/fail number.
  • Your full list of medicines and supplements.
  • Your health history, especially cancer, blood clots, stroke, heart disease, liver disease, migraines and any unexplained bleeding.
  • Three questions:
  1. Am I a candidate for hormone therapy?
  2. If not, or if I don't want it, which non-hormonal options fit me?
  3. Is anything else causing these symptoms?

Equelle hasn't helped enough? A clinician can look at what you've tried and talk through options with stronger evidence. When routine cash-pay online care fits your needs, review Gala's HRT offer and the medication and payment conditions above.

A clinician-led care option

Review Gala's $69 HRT offer

Not sure online care fits your history? Use Find My HRT Path to explore a featured option or guidance when an in-person visit is the better starting point. The tool does not medically clear you for online treatment.


When should you skip Equelle and see a clinician?

See a clinician rather than relying on another supplement purchase when you have bleeding after menopause, symptoms that affect safety or daily life, an undiscussed hormone-sensitive cancer history, or inadequate relief. A supplement review and a navigation quiz cannot rule out other causes. You do not have to complete twelve weeks before asking for help.

Online care can be a good fit for many routine menopause questions, medication discussions and follow-up. It isn't the right first step for everything:

  • Unexplained bleeding needs an in-person evaluation.
  • A complicated health history may need a specialist who can examine you.
  • An emergency needs emergency care.

The Menopause Society explains how to choose a clinician and links to its practitioner directory: find menopause care. Check the individual practitioner's credentials and services rather than assuming every directory entry has the same certification.


How we reviewed Equelle

This is a documentation review completed October 16, 2026. We read Equelle's public product, FAQ, research and purchaser-term pages; inspected the live review breakdown; read the cited study abstracts; and checked relevant Society guidance and prescription safety information. We did not buy, take or test Equelle or complete a clinical consult, and this page is not medically reviewed.

We use The HRT Index Verification Standard. These five public decision pillars group the more detailed criteria in our site methodology; they are not a numerical score:

PillarWhat we checked for Equelle
1. Clinical legitimacyWhat the product is (a dietary supplement, not an FDA-approved drug), who sells it, and what the published trials and The Menopause Society actually say
2. Care qualityEquelle sells a product, not medical care. We looked at customer support, the guarantee and how reviewers describe service.
3. Medication fitThe ingredient, directions, soy content, medicine-spacing warnings, and who should ask a clinician first
4. Price transparencyThree-bottle supply subtotals, published billing intervals, first-90-day and first-365-day charge scenarios, annualized-rate distinctions, promotions, and conflicting prices on Equelle pages
5. AccessWhere to buy, which purchases the guarantee covers, shipping, and HSA/FSA possibilities

We don't give Equelle a score. A made-up number would just be one more thing to second-guess.

What would change our view:

  • A large, independent, placebo-controlled trial in US women.
  • A peer-reviewed sleep result tested against placebo.
  • New Menopause Society guidance.
  • A change to Equelle's formula, price or guarantee.

We separate three things on this page: what companies say about themselves, what clinical sources show, and what we conclude as editors. Our full process is in our methodology. Found an error? Email partners@thehrtindex.com and we'll correct it with a dated note.


Equelle reviews FAQ

Does Equelle really work for hot flashes?

For some women, modestly. In the main placebo-controlled trial, S-equol reduced hot flashes by about 0.9 a day more than placebo, in postmenopausal Japanese women who started with about three a day. The Menopause Society doesn't recommend equol for hot flashes because the overall evidence is mixed.

How long does Equelle take to work?

Equelle says changes may appear around thirty days and fuller effects around three months. That is a brand timeline, not a promise. Keep a review date separate from the actual subscription cancellation deadline, which can arrive sooner; there is no universal day-71 cutoff.

What are Equelle's side effects?

Equelle warns that stomach upset can occur and suggests food for a sensitive stomach. The main twelve-week hot-flash trial reported no serious adverse events, and a separate small study lasted a year. That evidence cannot rule out uncommon or longer-term harms for every reader.

Is Equelle safe if I've had breast cancer?

Ask your oncology team first. S-equol binds estrogen receptors, and long-term safety data are limited. Equelle itself tells people with a breast cancer history to talk to their physician.

Does Equelle contain estrogen or hormones?

It contains no human or animal hormones, according to the brand. But S-equol is a soy-derived phytoestrogen: it has estrogen-like activity and binds preferentially to estrogen receptor beta. It is not the same thing as prescription estradiol.

Can I take Equelle with HRT or other medicines?

Ask the clinician managing your HRT and your pharmacist about this exact product. Equelle says to take it 4 hours apart from thyroid medicine and 1–2 hours apart from iron, because it contains calcium.

Does the research apply to perimenopause?

The main hot-flash trial summarized here does not establish the same benefit in perimenopause: it studied postmenopausal women. Equelle cites later research and marketing for a broader audience, but the full company sleep-study report was not verified for this review. A clinician can help assess symptoms while your periods are still changing.

Do I need a test to see if I make equol?

No validated consumer test was established in this review as necessary before buying Equelle or as a way to predict your personal benefit. The 2023 Society statement said producer-status tests were not commercially available then; we did not treat that dated statement as a current inventory of testing services. Study recruitment criteria are not a recommendation to buy a test.

How much does Equelle cost?

The published prices on October 16, 2026 were $111 every twelve weeks, $39.90 every four weeks, or $42 once per bottle. Three bottles cost $111–$126 before extras. With day 1 as the first charge and unchanged schedules, days 1–365 include five $111 charges ($555) or fourteen $39.90 charges ($558.60)—not simply twelve monthly payments. See the cost table for supply versus cash-flow math.

Is Equelle HSA or FSA eligible?

It may be. Equelle says you'll need a healthcare provider to complete its Letter of Medical Necessity, then submit it with your receipt to your account administrator. Reimbursement isn't guaranteed.

How does the money-back guarantee work?

First-time Equelle.com customers can request refunds for up to three bottles bought during the stated guarantee period by contacting Equelle within 120 days of first delivery. Amazon purchases go through the seller. Cancel at least five business days before a subscription processing date; confirm the account deadline and act earlier instead of waiting for the three-day reminder.

Who makes Equelle?

Equelle is sold by Bonafide Health, LLC, doing business as Equelle. Equelle's research page names Pharmavite as its parent company. A Japanese version is sold by Otsuka Pharmaceutical.

Is Equelle FDA approved?

No. It's a dietary supplement, and the FDA doesn't approve supplements before they're sold.

Does Equelle help with weight loss?

No clinical evidence establishing a weight-loss benefit was verified for this review. Equelle's published offer focuses on menopause symptoms and bone support, not weight-loss treatment.

Is Equelle better than Estroven?

They use different ingredients: S-equol vs rhubarb extract or black cohosh and soy. The Menopause Society recommended none of those ingredients for hot flashes. See our Estroven review.

Can I buy Equelle on Amazon or in stores?

Amazon listings exist, but Equelle's guarantee covers only first-time Equelle.com orders. Equelle says it isn't sold in stores.


Bottom line: should you try Equelle?

Equelle is a supplement with limited evidence, not the default answer for someone who wants to avoid hormones. A reader may still consider it after discussing safety, understanding the uncertainty and checking the purchase terms. When symptoms disrupt your life or a supplement has not helped enough, clinician-led care is worth discussing now—not only after another bottle.

The whole page in four lines:

  • The reviews: 4.2 stars from 2,715 on Equelle's site, with about 1 in 4 at three stars or fewer. Those ratings are not your chance of benefit.
  • The evidence: about 0.9 extra hot flashes a day reduced beyond placebo in the main trial. The Menopause Society does not recommend equol for hot flashes.
  • The cost: $111–$126 for three bottles before extras. Renewals can put more on your card within ninety days; see the supply and cash-flow totals separately.
  • The exit: first-time Equelle.com customers have a limited three-bottle guarantee and must request a qualifying refund within 120 days of first delivery. Cancel unwanted renewals at least five business days before processing, confirming the provider's actual cutoff.

Still not sure which kind of care fits, not just which bottle to buy? The free Find My HRT Path quiz asks about symptoms, what you've tried, age, state and relevant history. It then shows a featured care option or guidance when online care is not the right starting point. You don't have to decide about hormones before using it.

Choose a next step that fits

Take the free matching quiz

This page is educational and isn't medical advice. Talk with a qualified clinician before starting, stopping or combining supplements or medicines. In an emergency, call 911.


Sources

Equelle (all checked October 16, 2026)

Studies

Guidance and regulatory

Care providers

Reader discussion (language only, not evidence)

Additional product documents and resources


Keep reading